Accommodating individual travel history and unsampled diversity in Bayesian phylogeographic inference of SARS-CoV-2.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
09 10 2020
Historique:
received: 13 06 2020
accepted: 17 09 2020
entrez: 10 10 2020
pubmed: 11 10 2020
medline: 27 10 2020
Statut: epublish

Résumé

Spatiotemporal bias in genome sampling can severely confound discrete trait phylogeographic inference. This has impeded our ability to accurately track the spread of SARS-CoV-2, the virus responsible for the COVID-19 pandemic, despite the availability of unprecedented numbers of SARS-CoV-2 genomes. Here, we present an approach to integrate individual travel history data in Bayesian phylogeographic inference and apply it to the early spread of SARS-CoV-2. We demonstrate that including travel history data yields i) more realistic hypotheses of virus spread and ii) higher posterior predictive accuracy compared to including only sampling location. We further explore methods to ameliorate the impact of sampling bias by augmenting the phylogeographic analysis with lineages from undersampled locations. Our reconstructions reinforce specific transmission hypotheses suggested by the inclusion of travel history data, but also suggest alternative routes of virus migration that are plausible within the epidemiological context but are not apparent with current sampling efforts.

Identifiants

pubmed: 33037213
doi: 10.1038/s41467-020-18877-9
pii: 10.1038/s41467-020-18877-9
pmc: PMC7547076
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

5110

Subventions

Organisme : NIAID NIH HHS
ID : U19 AI135995
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI151812
Pays : United States

Commentaires et corrections

Type : UpdateOf

Références

Mol Biol Evol. 2019 Sep 1;36(9):2069-2085
pubmed: 31127303
Virus Evol. 2018 Jun 08;4(1):vey016
pubmed: 29942656
Philos Trans R Soc Lond B Biol Sci. 2008 Dec 27;363(1512):3985-95
pubmed: 18852111
Cell. 2019 Aug 22;178(5):1057-1071.e11
pubmed: 31442400
Syst Biol. 2017 Jan 1;66(1):e47-e65
pubmed: 28173504
Nat Microbiol. 2019 Jan;4(1):10-19
pubmed: 30546099
Virus Evol. 2020 Aug 19;6(2):veaa061
pubmed: 33235813
Virus Evol. 2016 Apr 09;2(1):vew007
pubmed: 27774300
Mol Biol Evol. 1993 Nov;10(6):1396-401
pubmed: 8277861
Science. 2020 Oct 30;370(6516):571-575
pubmed: 32913002
Nat Microbiol. 2020 Nov;5(11):1403-1407
pubmed: 32669681
Virus Evol. 2020 Apr 10;6(1):veaa027
pubmed: 32296544
Methods Mol Biol. 2009;537:39-64
pubmed: 19378139
JMIR Public Health Surveill. 2020 Jun 1;6(2):e19170
pubmed: 32412415
PLoS Genet. 2015 Aug 12;11(8):e1005421
pubmed: 26267488
J Mol Evol. 1985;22(2):160-74
pubmed: 3934395
Syst Biol. 2018 Sep 1;67(5):901-904
pubmed: 29718447
J Mol Evol. 1981;17(6):368-76
pubmed: 7288891
Proc Natl Acad Sci U S A. 1997 Jun 24;94(13):6815-9
pubmed: 9192648
Lancet Infect Dis. 2020 Jul;20(7):803-808
pubmed: 32246905
Nature. 2017 Apr 20;544(7650):309-315
pubmed: 28405027
J Clin Epidemiol. 2010 Aug;63(8):938-9; author reply 939
pubmed: 20189763
PLoS Pathog. 2019 Dec 6;15(12):e1007976
pubmed: 31809523
Science. 2014 Mar 28;343(6178):1520-2
pubmed: 24675962
Science. 2020 Jul 31;369(6503):582-587
pubmed: 32513865
Virus Evol. 2019 Feb 28;5(1):vey043
pubmed: 30838129
Bioinformatics. 2018 Dec 1;34(23):4121-4123
pubmed: 29790939
J Travel Med. 2020 Aug 20;27(5):
pubmed: 32419024
Euro Surveill. 2017 Mar 30;22(13):
pubmed: 28382917
Syst Biol. 2016 Nov;65(6):1041-1056
pubmed: 27368344
Mol Biol Evol. 2017 Nov 1;34(11):2970-2981
pubmed: 28666382
Cell. 2020 May 28;181(5):990-996.e5
pubmed: 32386545
Swiss Med Wkly. 2020 Feb 27;150:w20212
pubmed: 32227799
Mol Biol Evol. 2020 May 1;37(5):1530-1534
pubmed: 32011700
PLoS Med. 2020 Jul 17;17(7):e1003193
pubmed: 32678827
Viruses. 2020 Feb 05;12(2):
pubmed: 32033422
PLoS Pathog. 2014 Feb 20;10(2):e1003932
pubmed: 24586153
Nature. 2016 Feb 11;530(7589):228-232
pubmed: 26840485
Syst Biol. 2014 Jul;63(4):493-504
pubmed: 24627184
Mol Biol Evol. 2016 Aug;33(8):2102-16
pubmed: 27189573
Mol Biol Evol. 2020 Nov 1;37(11):3363-3379
pubmed: 32895707
Ann Intern Med. 2020 May 05;172(9):577-582
pubmed: 32150748
Nat Commun. 2020 Oct 9;11(1):5110
pubmed: 33037213
Bull Math Biol. 2020 Apr 8;82(4):52
pubmed: 32270376
Bioinformatics. 2018 Sep 15;34(18):3094-3100
pubmed: 29750242
Syst Biol. 2019 Nov 1;68(6):1052-1061
pubmed: 31034053
Cell. 2020 May 28;181(5):997-1003.e9
pubmed: 32359424
PLoS Comput Biol. 2009 Sep;5(9):e1000520
pubmed: 19779555

Auteurs

Philippe Lemey (P)

Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, Laboratory of Clinical and Evolutionary Virology, Leuven, Belgium. philippe.lemey@kuleuven.be.

Samuel L Hong (SL)

Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, Laboratory of Clinical and Evolutionary Virology, Leuven, Belgium.

Verity Hill (V)

Institute of Evolutionary Biology, University of Edinburgh, Edinburgh, EH9 3FL, UK.

Guy Baele (G)

Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, Laboratory of Clinical and Evolutionary Virology, Leuven, Belgium.

Chiara Poletto (C)

INSERM, Sorbonne Université, Institut Pierre Louis d'Epidémiologie et de Santé Publique IPLESP, F75012, Paris, France.

Vittoria Colizza (V)

INSERM, Sorbonne Université, Institut Pierre Louis d'Epidémiologie et de Santé Publique IPLESP, F75012, Paris, France.

Áine O'Toole (Á)

Institute of Evolutionary Biology, University of Edinburgh, Edinburgh, EH9 3FL, UK.

John T McCrone (JT)

Institute of Evolutionary Biology, University of Edinburgh, Edinburgh, EH9 3FL, UK.

Kristian G Andersen (KG)

Department of Immunology and Microbiology, Scripps Research, La Jolla, CA, 92037, USA.

Michael Worobey (M)

Department of Ecology and Evolutionary Biology, University of Arizona, Tucson, AZ, 85721, USA.

Martha I Nelson (MI)

Division of International Epidemiology and Population Studies, Fogarty International Center, National Institutes of Health, Bethesda, MD, 20892, USA.

Andrew Rambaut (A)

Institute of Evolutionary Biology, University of Edinburgh, Edinburgh, EH9 3FL, UK.

Marc A Suchard (MA)

Department of Biomathematics, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, 90095, USA. msuchard@ucla.edu.
Department of Biostatistics, Fielding School of Public Health, University of California Los Angeles, Los Angeles, CA, 90095, USA. msuchard@ucla.edu.
Department of Human Genetics, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, 90095, USA. msuchard@ucla.edu.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH